You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

molecular mimicry

Showing 1 - 25 of 4,985
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prognostic Factors of Gullian Barrie Syndrome Outcome

Completed
  • Guillain-Barre Syndrome
  • plasmapheresis
  • Assuit, Assiut, Egypt
    Assiut university
Dec 7, 2022

Security Efficacy COVID-19 Vaccination

Completed
  • Autoimmune State
  • SARS-CoV-2 Infection
  • Blood sampling
  • Milan, Italy
    Istituto Auxologico Italiano IRCCS
Feb 23, 2023

Living Donor Liver Transplantation Trial in Pittsburgh (Donor-derived DCreg)

Active, not recruiting
  • Living Donor Liver Transplantation
  • Donor-derived DCreg
  • Pittsburgh, Pennsylvania
    UPMC
Sep 7, 2022

Occurrence of Antibodies Cross-reacting With Autoantigens in

Recruiting
  • Epstein-Barr Virus (EBV) Infection
  • Data collection: Participant characteristics (Illness course, complications of primary EBV infection and provided treatments)
  • +2 more
  • Basel, Switzerland
    University Hospital Basel, Division of Internal Medicine
Nov 8, 2021

Healthy Nutrition Trial in Almada (Bitter taste perception, Salty taste perception, Sweet taste perception)

Completed
  • Healthy Nutrition
  • Bitter taste perception
  • +4 more
  • Almada, Monte De Caparica, Portugal
    Instituto Universitário Egas Moniz
Sep 20, 2023

Sequelae of; Infection, Post Infection Glomerulonephritis, Post-Infectious Peripheral Neuralgia Trial in Rockville (PurWet,

Recruiting
  • Sequelae of; Infection
  • +17 more
  • PurWet
  • +6 more
  • Rockville, Maryland
    All Natural Medicine Clinic, LLC
May 23, 2021

Post-COVID-19 Syndrome, Post-COVID Syndrome, Post COVID-19 Condition Trial in Mainz (Immunoadsorption, Sham-apheresis)

Recruiting
  • Post-COVID-19 Syndrome
  • +2 more
  • Immunoadsorption
  • Sham-apheresis
  • Mainz, Rheinland-Pfalz, Germany
    UNIVERSITÄTSMEDIZIN der Johannes Gutenberg-Universität Mainz I.
May 2, 2023

Type 1 Diabetes Trial in Taichung (L. johnsonii MH-68, B. animalis subsp. lactis CP-9 and L. salivarius AP-32, Placebo)

Completed
  • Type 1 Diabetes Mellitus
  • L. johnsonii MH-68, B. animalis subsp. lactis CP-9 and L. salivarius AP-32
  • Placebo
  • Taichung, Taiwan
    China Medical University Hospital
Aug 2, 2021

Rheumatic Heart Disease Trial in Kigali (Next generation sequencing)

Recruiting
  • Rheumatic Heart Disease
  • Next generation sequencing
  • Kigali, Rwanda
    University of Rwanda
May 7, 2021

Electromyography, Eye-tracking, Facial Palsy Trial in Amiens (dental impressions, Simultaneous MoCap and EMG acquisition,

Recruiting
  • Electromyography
  • +2 more
  • dental impressions
  • +3 more
  • Amiens, Picardie, France
    CHU Amiens Picardie
Oct 25, 2022

Vaccines in Italian MS Patients

Recruiting
  • Multiple Sclerosis
    • Siena, SI, Italy
      university of Siena
    Nov 15, 2022

    Alzheimer Trial in Sausalito (Lifestyle medicine)

    Active, not recruiting
    • Alzheimer Disease
    • Lifestyle medicine
    • San Diego, California
    • +3 more
    Sep 13, 2022

    Clinical Significance of Anti-annexin A2 Antibodies in COVID-19

    Recruiting
    • COVID-19
      • Amiens, France
        CHU Amiens
      Feb 17, 2022

      Infections in Lung Transplantation

      Recruiting
      • Lung Transplant Infection
      • +4 more
      • BioFire Pneumonia Panel Plus
      • Milano, Italy
        Irccs Fondazione Ca' Granda Policlinico Di Milano
      Jul 17, 2023

      Cancer Trial in Berlin

      Recruiting
      • Cancer
        • Berlin, Germany
          Charité Comprehensive Cancer Center
        Jun 21, 2023

        A Retrospective Study on Multiple Classifier Endometrial Cancer

        Recruiting
        • Uterine Cancer
        • Observation only
        • Milan, Italy
          Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
        Jul 27, 2023

        FSHD Molecular Characterization

        Recruiting
        • Facio-Scapulo-Humeral Dystrophy
          • Columbus, Ohio
            The Abigail Wexner Research Institute at Nationwide Children's H
          Oct 20, 2023

          Rare Cancers, Multiomics Trial in Heidelberg

          Recruiting
          • Rare Cancers
          • Multiomics
            • Heidelberg, Germany
              German Cancer Research Center
            May 2, 2023

            Anticoagulant, Venous Thromboembolism, Prophylaxis Trial in Denmark (Dalteparin Prefilled Syringe, Tinzaparin profiled syringe)

            Recruiting
            • Anticoagulant
            • +3 more
            • Dalteparin Prefilled Syringe
            • Tinzaparin profiled syringe
            • Copenhagen, Denmark
            • +8 more
            Aug 29, 2023

            Determining Individualized Cancer Therapy in Pancreatic Cancer

            Not yet recruiting
            • Pancreatic Neoplasms
            • Targeted Therapy
            • Milwaukee, Wisconsin
              Froedtert Hospital and the Medical College of Wisconsin
            Jun 14, 2023

            Renal Cell Carcinoma Trial in Birmingham (Pembrolizumab injection)

            Not yet recruiting
            • Renal Cell Carcinoma
            • Pembrolizumab injection
            • Birmingham, Alabama
              University of Alabama at Birmingham
            Aug 20, 2023

            Stage III Solid Tumors, Stage IV Solid Tumors Trial (Comprehensive molecular panel test, EORTC QLQ-30)

            Not yet recruiting
            • Stage III Solid Tumors
            • Stage IV Solid Tumors
            • Comprehensive molecular panel test
            • EORTC QLQ-30
            • (no location specified)
            Jan 25, 2023

            Rare Malignant Tumor Trial (Imatinib)

            Not yet recruiting
            • Rare Malignant Neoplasm
            • (no location specified)
            Nov 1, 2023

            CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

            Recruiting
            • CML
            • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
            • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
              FUNDALEU
            Jun 29, 2023

            Dialysis; Complications, Bleeding Trial in Wonju (Nafamostat Mesylate)

            Recruiting
            • Dialysis; Complications
            • Bleeding
            • Nafamostat Mesylate
            • Wonju, Kangwondo, Korea, Republic of
              Yonsei Unviersity Wonju College of Medicin
            May 22, 2023